Chemistry

Event Profile: International Water & Effluent Exhibition (IWEX) which takes place at the NEC, is the UK's premier international water show and the 2007 edition promises to be the largest and busiest IWEX ever. Since its launch the event has developed into a forum for networking and training as well as one of the largest exhibitions of its type in Europe. Highlights: The IWEX event oncorporates a number of key seminars for professionals within the water industry looking at the challenges and opportunities arising within our industry. These will include debates regarding legislation, academic reviews of the latest technological advances and workshops on the practical implications. Visitor's Profile: IWEX is aimed at the following job descriptions: Engineering - chemical, civil, design, electrical, mechanical, process, Company Management - Chief Executives, Managing Directors, General Managers, Chairmen, Owners, Finance, Buyers/Purchasers, Health and safety, Operations, Plant/Site Management Production, Research/Development/Scientific, Sales & Marketing/Business, Development. Exhibitor's Profile: IWEX is the UK's no.1 marketplace for supplying to the water industry including: Contractors, Industrial water users, Utility providers, Government, Environmental agencies etc. Held every two years, the event has developed into a forum for networking and training as well as one of the largest exhibitions of its type in Europe. Organizer: Faversham House Group Limited Faversham House, 232a Addington Road, South Croydon, Surrey, United Kingdom. Tel: +(44)-(20)-86517100 Fax: +(44)-(20)-86517117

Environmental Monitoring & OSPAR Compliance 2008 26 to 28 February 2008 Aberdeen, United Kingdom Website: http://www.iqpc.com/uk/ospar Contact name: Swaantje Buss Attending Energy IQ’s Environmental Monitoring & OSPAR Compliance 2008 will enable you to enhance your oil-in-water monitoring processes and ensure you are complying fully with the latest OSPAR regulations. Organized by: IQPC

This conference will provide the participants with the current trends of the CEE chemical and petrochemical industry, the latest stage of its development, business opportunities and conditions for expected future growth. It is a unique opportunity for executives to discuss recent market approach, regional strategies for growth, and future plans of both local and western players. With ongoing consolidation and unfinished privatization still having a large influence on market developments, players are at the same time fully engaged in increasing their production capacity. New (supra)regional growth strategies are being found focusing on niche markets in the highly developed countries and simultaneous expansion towards the SEE region. Meanwhile CEE producers find themselves competing more and more with their major global rivals and new competitors from the MRIC countries in fulfilling the still growing consumption demand throughout the CEE region. Next to that analysts predict a period of declining economic growth in the CEE region, making the challenge to maintain profitability even stronger. Chemical and petrochemical groups with strong international presence are feeling need to respond by revising their business strategies and/or optimizing their operating efficiency to be able to compete in a rapidly maturing market. Against the background of these current challenges, chemical and petrochemical companies are revising their strategies and are trying to create (cross regional) alliances in order to keep their market value at a high level and be ready at all times to serve existing and future clients.

A Two-Day Comprehensive & Interactive Course with Workshops on: - FDA's Center for Devices and Radiological Health Investigations - Clarifying FDA Classification of Medical Devices - Memoranda of Understanding (MOU) - Developing QSR/GMP/ISO for combo products - Principals of ICH GCP for Medical Devices - Definitions and Classifications of Medical Device - The Premarket Notification (510K) Summaries and Reviews - Investigational Device Exemption (IDE) Applications - Premarket Approval (PMA) Review Process - Safety and Effectiveness Requirements - Humanitarian Device Exemption (HDE) - Post Market Obligations - Managing Recalls and Problem Reporting - Planning and Implementing an Clinical Audit - Determining a Regulatory Strategy - Clinical Trials for Medical Devices - Sponsor Obligations - Inspection and Audit of Vendors - FDA Notification procedures Distinguished Course Leaders Martha A. Feldman, RAC President & CEO Drug & Device Development Co., Inc. Albert A. Ghignone, MS, RAC CEO AAG Incorporated

The population is rapidly getting older as the baby boomers turn 65. Exploding with it is the field of aging research. For many years there has been a small group of scientists, gerontologists, studying the reasons we age; how, and can we slow down the process. In recent years many more scientists have joined the field. This has led to a questioning of old and established theories as well as the putting forth of new theories. Some scientists look at aging as a disease that we can cure. Others think of it as an inevitable process that perhaps we can slow down. And yet others think aging is the process of living but hopefully we can cure the diseases associated with aging. This conference will discuss these many theories and the inevitable debates that go with it. Through a format of presentations, panels, and networking, scientists established in the field and ones just entering will be able to explore the latest issues in this important and young field.

Main Topics: Pediatrics, child health, biological anthropology, growth and development, body composition, clinical nutrition, community medicine, cytogenetics and biochemical genetics, dermatology and venereal diseases, disability and mental health, endocrinology and diabetes, environmental health impacts, histopathology, laboratory medicine, molecular and immunogenetics, oro-dental diseases, pharmacology and toxicology, prenatal genetics, reproductive health, gynecology and obstetrics, and free papers in medical sciences. Registration fees: US$ 150 which include: opening ceremony, admission to scientific sessions, admission to technical exhibitions, conference kit, certificate of attendance, coffee and lunch breaks. Accommodation: Accommodation can be arranged on request. Payment: Bank trasfere: National Bank of Egypt, Cairo, Account No. 9/450/81761/1. Email: Nrc_med@yahoo.com Contact person: Prof. Dr. Ashraf Shaalan Head of Medical Research Division National Research Centre Cairo, Egypt.

Having received Royal Assent on the 17th of July, Mental Health Practitioners across the country are now faced with the task of implementing the Mental Health Act 2007. Health Service Journal is delighted to present this timely and essential conference which will provide you with practical guidance on how to turn the policy into practice. Insightful presentations delivered by national authorities and pioneering implementers will enable you to: Implement Supervised Community Treatment (SCT) Utilise new workforce roles Apply the Deprivation of Liberty safeguards Assess the impact of amendments on Black and Ethnic Minority Groups Gain clarification on the changing face of Mental Health Tribunals Establish and commission appropriate advocacy services Develop age appropriate services Who should attend? This conference is essential for all practitioners who need to understand, and abide by, the Mental Health Act 2007. Whether you work at a Mental Health Trust, PCT or Local Authority, attend this conference to gain the tools and knowledge you need to prepare for national roll-out of the new Act. Debate, share and exchange ideas Our panel discussion and Q&A sessions will provide an excellent opportunity for delegates to trade ideas and closely question experts on specific issues. With plenty of time for networking, this is your chance to exchange concerns and benchmark with national authorities and pioneers.

The purpose of our IV ESRA Winter Week is to once again promote regional anaesthesia in the relaxed atmosphere of the Swiss Alps. The scientific programme is a mix of state-of-the-art lectures, discussions, hands-on workshops and video presentations. The scientific programme which has been developed to take place during early morning and late afternoon thereby allowing the participants to take advantage of wintersport or the many other leisure activities that this region has to offer.

This conference will cover many important fundamental aspects of the role of cytokine and inflammation as related drug discovery and development, including current drugs, progress of potential drugs in pre-clinical and clinical trials, and new research and development in this field. We hope to achieve this goal by bringing together conceptual innovators from all active parties who certainly include scientists, industry leaders, entrepreneurs, and regulators. You can find our full conference calendar through 2008 at: http://www.gtcbio.com/events_gtcbio.pdf

7th Annual Cool Chain Europe Pharma IQ's flagship annual Cool Chain event, bringing together the continent's biggest collection of cold chain professionals every year. This event is presented in English January 29 - 30, 2008 • Sheraton Brussels Hotel and Towers, Brussels, Belgium The 7th Annual Cool Chain Europe will build on the feedback from the past 6 European annual events to deliver an essential learning and networking forum. For 2008 we will take a closer look at how the QA/Logistics integrated relationship is affecting buying decisions and cool chain operations, also, in addition we will examine key developments in: • Regulations, physical distribution, temperature monitoring of room temperature or temperate chain distribution (<25°C) • Developments in the qualification of trailers or active refrigeration systems • Implementing stability studies based on product requirements • Country specific temperature profiles • Regulatory assessment of new products and shipment validation • Providing guidance to down stream handlers of biotech products • Identifying temperature requirements and designing compliant systems www.iqpc-pharma.com/be/coolchaineurope/ediary